Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Relypsa reports data on part A of its phase III patiromer trial

Sep. 16, 2013

ChemoCentryx reports interim data for CCX-140 in patients with diabetic nephropathy

Sep. 13, 2013

Genkyotex obtains IND approval for phase II study of GKT-137831

Sep. 9, 2013

Rockwell Medical reports findings from CRUISE-2 study of SFP

Sep. 5, 2013

Swissmedic opposes approval of Vitaros

Sep. 3, 2013

Fedovapagon tested as potential therapy for nocturia associated with BPH

Sep. 2, 2013

Pilocarpine/tolterodine fixed-dose combination is well tolerated at increased total daily doses

Sep. 2, 2013

FDA issues tolvaptan CRL for kidney disease

Aug. 30, 2013

FDA extends PDUFA goal date for Xiaflex

Aug. 29, 2013

TRPM8 blockade as a potential new treatment strategy for urinary bladder disorders

Aug. 29, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...